MeSH term
Frequency | Condition_Probility | Animals | 9 | 0.0 |
Humans | 22 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Active Transport, Cell Nucleus | 7 | 2.0 |
Amino Acid Sequence | 12 | 0.0 |
Cell Line | 8 | 0.0 |
Cell Nucleus/*metabolism | 7 | 1.0 |
Cloning, Molecular | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
Cytoplasm/metabolism | 5 | 0.0 |
Hela Cells | 7 | 0.0 |
Karyopherins/*metabolism | 2 | 40.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
RNA, Viral/metabolism | 2 | 2.0 |
*Receptors, Cytoplasmic and Nuclear | 6 | 6.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Phosphorylation | 4 | 0.0 |
Models, Genetic | 2 | 0.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Transfection | 3 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
Subcellular Fractions | 3 | 1.0 |
Mutagenesis | 2 | 0.0 |
Mutation | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Adult | 2 | 0.0 |
Female | 3 | 0.0 |
3T3 Cells | 2 | 0.0 |
*Karyopherins | 3 | 13.0 |
Mice | 3 | 0.0 |
COS Cells | 2 | 0.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Gene Products, rev/*metabolism | 3 | 30.0 |
Biological Transport | 2 | 0.0 |
HIV-1/*metabolism | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Dimerization | 2 | 0.0 |
Cytoplasm/*metabolism | 2 | 1.0 |
Karyopherins/metabolism | 3 | 14.0 |
Receptors, Cytoplasmic and Nuclear/metabolism | 2 | 1.0 |
Active Transport, Cell Nucleus/physiology | 2 | 3.0 |
Leucine/metabolism | 2 | 3.0 |
